COMPANIES TO WATCH

• Companies To Watch: Vivani Medical

  Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and possibly one full year. The company's lead program is an exenatide implant.

• Companies To Watch: Imunon

  Imunon aims to shake up the standard of care in the frontline treatment of advanced ovarian cancer.

• Companies To Watch: Senti Bio

  Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of identifying cancer targets on both healthy and diseased cells.

• Companies To Watch: Terns Pharmaceuticals

  Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small molecules.

WHERE ARE THEY NOW

• Where Are They Now? Life Science Cares

  Life Science Cares, an industry philanthropic organization, turns 10 in April. Now in five cities and Switzerland, the organization remains focused on fighting poverty.

• Where Are They Now? Tarsus Pharmaceuticals

  Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and irritation in the eyelid. A new consumer DTC campaign, potential global approvals, and a new indication in the clinic could turn Xdemvy into a blockbuster drug.

• Where Are They Now? Teva Pharmaceuticals

  Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, and branded drugs to set the company back on track, or back to the future.